1161 Synthetic CD206 targeted constructs carrying pacletaxel or novel bisphosphonate payloads alter macrophages towards pro-inflammatory phenotypes; the paclitaxel construct improves the efficacy of anti-CTLA4 in CT26 tumors
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.